Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Arizona Clinical Trials, Chandler, Arizona Golden State Urology, Sacramento, California Emory University, Atlanta, Georgia Michigan Institute of Urology & Solaris Health, Troy, Michigan SUNY Upstate Medical University, Syracuse, New York MidLantic Urology, Cynwyd, Pennsylvania Conrad Pearson Clinic, Germantown, Tennessee Urology Associates, P.C., Nashville, Tennessee Potamac Urology Center, Alexandria, Virginia